AVI BioPharma, Inc.
Biotech firm reports loss of $0.14 per share
Published in Pharma Investments, Ventures and Law Weekly, April 10th, 2005
For the fourth quarter of 2004, AVI reported a net loss of $5.0 million, or $0.14 per share, compared with a net loss of $3.1 million, or $0.10 per share, for the fourth quarter of 2003. Revenues for the fourth quarter of 2004 were $285,588, compared with $135,181 for the fourth quarter of 2003.
Research and development (R&D) expenses decreased to $3.8 million in the fourth quarter of 2004, compared with $6.4 million in the fourth quarter of 2003. Approximately $2.3 million of this R&D decrease was due to lower contracting costs for the production...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
Pharmaceutical firm reports 11% increase in revenues, provides clinical update - AIDS Healthcare Foundation
Legal order allows challenge to AIDS drug pricing in South African to go forward - Able Laboratories, Inc.
Pharmaceutical firm reports 54.7% increase in gross profits - Adolor Corporation
Biopharmaceutical firm reports loss of $1.12 per share - Aksys, Ltd.
Dialysis product maker reports loss of $0.26 per share - Alantos Pharmaceuticals Holding, Inc.
Biopharmaceutical company raises $20M in private placement - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
